Risk factors for pediatric stroke: consequences for therapy and quality of life

Burkhard Simma1, Gertraud Martin, Thomas Müller

  • 1Department of Pediatrics, Academic Teaching Hospital, Landeskrankenhaus Feldkirch, Feldkirch, Austria. burkhard.simma@lkhf.at

Pediatric Neurology
|August 7, 2007
PubMed

Insights

Pediatric stroke incidence is higher than previously thought, with vasculopathy and lipometabolic disorders being key risk factors. Early therapeutic interventions positively influence long-term outcomes in children with stroke.

Area of Science:

  • Neurology
  • Pediatrics
  • Epidemiology

Background:

  • Pediatric stroke is a significant health concern with varying incidence rates.
  • Understanding risk factors and long-term outcomes is crucial for optimizing treatment.

Purpose of the Study:

  • To determine the incidence of pediatric stroke.
  • To identify associated risk factors.
  • To evaluate long-term outcomes and inform therapeutic strategies.

Main Methods:

  • A retrospective, population-based study of pediatric stroke patients (age >1 month and <19 years) in Vorarlberg, Austria (1984-2005).
  • Analysis of neurological deficits, neuropsychological measures, quality of life, and therapeutic interventions.
  • Calculation of incidence rates for ischemic and hemorrhagic stroke.

Main Results:

  • The incidence was 1.96/100,000 child-years for ischemic stroke and 0.74/100,000 child-years for hemorrhagic stroke.
  • Vasculopathy (85%) and lipometabolic disorders (85%) were the most common risk factors.
  • Therapeutic consequences were implemented in 65% of cases, including aspirin, folic acid, and rehabilitation.

Conclusions:

  • Pediatric stroke often presents with multiple risk factors, primarily vasculopathies and elevated lipoprotein(a).
  • Neurological deficits are the primary determinant of outcome.
  • A good quality of life positively influences the overall outcome in pediatric stroke survivors.

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...